NCT07127757 is a clinical trial of Wavelight Plus LASIK in Myopia, sponsored by Laser Defined Vision.

Who is sponsoring NCT07127757?

NCT07127757 is sponsored by Laser Defined Vision.

What drugs are being tested in NCT07127757?

Interventions in NCT07127757: Wavelight Plus LASIK.

What condition does NCT07127757 study?

NCT07127757 studies Myopia, Astigmatism.

Is NCT07127757 still recruiting?

NCT07127757 is currently recruiting now. Last updated 2 October 2025.

Last reviewed 2025-10-02 · How we verify

NCT07127757

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Evaluation of WaveLight Plus LASIK

Recruiting now Last updated 2 October 2025

What this trial tests

trial testing Wavelight Plus LASIK in Myopia in 50 participants. Currently enrolling.

Timeline

28 August 2025

Primary endpoint
1 September 2026

1 September 2026

Quick facts

Lead sponsor	Laser Defined Vision
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	50
Start date	28 August 2025
Primary completion	1 September 2026
Estimated completion	1 September 2026
Sites	1 location across United States

Drugs / interventions tested

Wavelight Plus LASIK

Conditions studied

Myopia — all drugs for Myopia →
Astigmatism — all drugs for Astigmatism →

Sponsor

Laser Defined Vision

Who can join

18 and older, any sex, with Myopia or Astigmatism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a single-site, single-arm, prospective, observational study of subject satisfaction, quality of vision, and quality of life after bilateral LASIK surgery. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the adapted PROWL and Low Luminance Questionnaire (LLQ-32) Questionnaire.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
NCT07229365 — Children's Viewing Behavior · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07127757 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Laser Defined Vision
Last refreshed: 2 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07127757.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing